Development, production and distribution of medical devices for tumor cryoablation

IBN SINA TECHNOLOGY

Seveso (IT) · Tianjin (CN, production partner Medinux)New on Amplifa

15+ yearsTeam experience in tumor cryoablation

2,000 m²Production hall Medinux (Tianjin)

Class 100,000Clean room for medical devices

MENA & EuropeDistribution region

About IBN SINA TECHNOLOGY

IBN SINA TECHNOLOGY (IST) is a medical innovation technology company with its own intellectual property that develops, produces and distributes new products. The focus is on tumor cryoablation devices, tumor detection as well as cryopreservation of tissue and organs. The team has more than 15 years of experience in the development, introduction and distribution of cryoablation medical devices and maintains close cooperation with hospitals in the MENA region and abroad. The company is headquartered in Seveso (Province of Monza and Brianza, Italy) and is the main distributor of Medinux (Tianjin) Technologies Co., Ltd. for the MENA region and Europe. Medinux (Tianjin)'s R&D and production base on the coast of the Bohai Sea comprises a production hall of approximately 2,000 m² and a Class 100,000 clean room; according to the company, the R&D and production processes are carried out in accordance with GMP standards.

Site: Seveso (MB)
Processes: Medical device development and production (tumor cryoablation devices), Distribution of medical devices, Cryoablation technology, Training and clinical support for hospitals, R&D and production (partner Medinux Tianjin)
Materials: GMP production standards
Certificates: GMP standards
Industries: Medical technology, Oncology, Tumor ablation, Cryotechnology, Tissue and organ preservation

01
R&D and product development
02
Patent and trademark protection
03
Production (partner Medinux, Tianjin, GMP clean room)
04
Distribution MENA & Europe
05
Training and clinical support for hospitals

Processes & Standards

GMP

GMP production standards

According to the company, R&D and production of the medical devices are carried out in accordance with GMP standards.

Locations

Seveso

Site/office and distribution

Medinux (Tianjin)

R&D, development and production base (partner)

Production hall approx. 2,000 m²
Class 100,000 clean room

Products

**Cryoablation device technology**Medical device · Oncology

Inside the production

Industries

Medical technologyOncologyTumor ablationCryotechnologyTissue and organ preservation

Processes & technical limits

Processes	Tolerance	Max. part	Weight	Lot size	Materials
Medical device development and production (tumor cryoablation devices)Assembly	–	–	–	–	Medical materials not specified

2 Anlagen & Maschinen

Machine	Manufacturer / model	Quantity	Working area	Year built	Site
Clean room (Class 100,000 clean room)	–	1	–	–	Medinux (Tianjin), China
Production plant	–	1	approx. 2,000 m²	–	Medinux (Tianjin), China

Additional services

Distribution of medical devicesCryoablation technologyTraining and clinical support for hospitalsR&D and production (partner Medinux Tianjin)

Reference customers

Hospitals in the MENA region

Quality & Compliance

According to the company, R&D and production are carried out in compliance with GMP standards; the products are protected by comprehensive patent and trademark protection.

Evidence	Seveso
GMP standards

Company & Team

Team with over 15 years of experience in the development, introduction and distribution of tumor cryoablation devices
Two innovative product technologies selected among the ten significant medical technology inventions of the USA; comprehensive patent and trademark applications filed domestically and internationally